Delivery Order SPE2DB24D2106-SPE2DB24FAUTC

Award Date 8/19/24
Potential Completion Date 8/20/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $65,765.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the SPE2DB program, an Indefinite Delivery Contract (IDC) with a ceiling value of $499,999,999 that enables the DLA to issue firm fixed-price orders for a comprehensive range of pharmaceutical products, including branded and generic...
This federal contract award is a delivery order worth $8,220.68 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price award for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through March 17, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $24,662.04 firm fixed-price delivery order contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,220.68 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
This federal contract award is a delivery order valued at $57,544.76, issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price agreement for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the medical needs of military healthcare facilities. The contract is not associated with any set-aside designation,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGE to support medical needs, with a completion date of July 10, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,499.90 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, with a period of performance through July 16, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $16,249.95 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, with a completion date of June 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a delivery order valued at $8,220.68, is for the supply of STELARA 90 MG/ML SYRINGE ML, a pharmaceutical product. The contract is a firm fixed-price delivery order that is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUTC
    Delivery Order

This federal contract award, valued at $7,824.35, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), which has a ceiling value of up to $499,999,999 and runs through December 31, 2025.

Under this contract, DMS Pharmaceutical Group will provide the DLA with STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The award has no set-aside designation. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 11/18/24, 9:25 AM